サマリー

市場分析と洞察。爪真菌症治療の世界市場
爪真菌症治療の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の爪水虫治療市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には、収益面での世界の爪水虫治療市場の全体的なサイズも含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の爪甲真菌症治療市場で永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の爪甲真菌症治療市場を詳細に調査するために、独自の業界最高の調査・分析手法を用いています。

爪真菌症治療の世界的な規模と市場規模
爪水虫治療市場は、企業別、地域（国）別、タイプ別、用途別に分類されています。世界のOnychomycosis Treatment市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
薬物療法
レーザー機器
フォトダイナミックセラピー

用途別セグメント
病院
皮膚科医院
小売薬局
オンライン薬局

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
ファイザー
ノバルティス
ジョンソン・エンド・ジョンソン
バウシュ・ヘルス
バイエル
Lumenis
ガルデルマ
モバーグ・ファーマ
シプラ
Biofrontera
レオ・ファーマ
ドクター・レッジーズ・ラボラトリーズ
メディメトリクス・ファーマシューティカルズ

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Onychomycosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Lasers
1.2.4 Photodynamic Therapy
1.3 Market by Application
1.3.1 Global Onychomycosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Retail Pharmacies
1.3.5 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Onychomycosis Treatment Market Perspective (2016-2027)
2.2 Onychomycosis Treatment Growth Trends by Regions
2.2.1 Onychomycosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Onychomycosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Onychomycosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Onychomycosis Treatment Industry Dynamic
2.3.1 Onychomycosis Treatment Market Trends
2.3.2 Onychomycosis Treatment Market Drivers
2.3.3 Onychomycosis Treatment Market Challenges
2.3.4 Onychomycosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Onychomycosis Treatment Players by Revenue
3.1.1 Global Top Onychomycosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Onychomycosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Onychomycosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Onychomycosis Treatment Revenue
3.4 Global Onychomycosis Treatment Market Concentration Ratio
3.4.1 Global Onychomycosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Onychomycosis Treatment Revenue in 2020
3.5 Onychomycosis Treatment Key Players Head office and Area Served
3.6 Key Players Onychomycosis Treatment Product Solution and Service
3.7 Date of Enter into Onychomycosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Onychomycosis Treatment Breakdown Data by Type
4.1 Global Onychomycosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Onychomycosis Treatment Forecasted Market Size by Type (2022-2027)

5 Onychomycosis Treatment Breakdown Data by Application
5.1 Global Onychomycosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Onychomycosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Onychomycosis Treatment Market Size (2016-2027)
6.2 North America Onychomycosis Treatment Market Size by Type
6.2.1 North America Onychomycosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Onychomycosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Onychomycosis Treatment Market Size by Type (2016-2027)
6.3 North America Onychomycosis Treatment Market Size by Application
6.3.1 North America Onychomycosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Onychomycosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Onychomycosis Treatment Market Size by Application (2016-2027)
6.4 North America Onychomycosis Treatment Market Size by Country
6.4.1 North America Onychomycosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Onychomycosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Onychomycosis Treatment Market Size (2016-2027)
7.2 Europe Onychomycosis Treatment Market Size by Type
7.2.1 Europe Onychomycosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Onychomycosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Onychomycosis Treatment Market Size by Type (2016-2027)
7.3 Europe Onychomycosis Treatment Market Size by Application
7.3.1 Europe Onychomycosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Onychomycosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Onychomycosis Treatment Market Size by Application (2016-2027)
7.4 Europe Onychomycosis Treatment Market Size by Country
7.4.1 Europe Onychomycosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Onychomycosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Onychomycosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Onychomycosis Treatment Market Size by Type
8.2.1 Asia-Pacific Onychomycosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Onychomycosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Onychomycosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Onychomycosis Treatment Market Size by Application
8.3.1 Asia-Pacific Onychomycosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Onychomycosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Onychomycosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Onychomycosis Treatment Market Size by Region
8.4.1 Asia-Pacific Onychomycosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Onychomycosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Onychomycosis Treatment Market Size (2016-2027)
9.2 Latin America Onychomycosis Treatment Market Size by Type
9.2.1 Latin America Onychomycosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Onychomycosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Onychomycosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Onychomycosis Treatment Market Size by Application
9.3.1 Latin America Onychomycosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Onychomycosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Onychomycosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Onychomycosis Treatment Market Size by Country
9.4.1 Latin America Onychomycosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Onychomycosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Onychomycosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Onychomycosis Treatment Market Size by Type
10.2.1 Middle East & Africa Onychomycosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Onychomycosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Onychomycosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Onychomycosis Treatment Market Size by Application
10.3.1 Middle East & Africa Onychomycosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Onychomycosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Onychomycosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Onychomycosis Treatment Market Size by Country
10.4.1 Middle East & Africa Onychomycosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Onychomycosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Onychomycosis Treatment Introduction
11.1.4 Pfizer Revenue in Onychomycosis Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Onychomycosis Treatment Introduction
11.2.4 Novartis Revenue in Onychomycosis Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Onychomycosis Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Onychomycosis Treatment Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Bausch Health
11.4.1 Bausch Health Company Details
11.4.2 Bausch Health Business Overview
11.4.3 Bausch Health Onychomycosis Treatment Introduction
11.4.4 Bausch Health Revenue in Onychomycosis Treatment Business (2016-2021)
11.4.5 Bausch Health Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Onychomycosis Treatment Introduction
11.5.4 Bayer Revenue in Onychomycosis Treatment Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Lumenis
11.6.1 Lumenis Company Details
11.6.2 Lumenis Business Overview
11.6.3 Lumenis Onychomycosis Treatment Introduction
11.6.4 Lumenis Revenue in Onychomycosis Treatment Business (2016-2021)
11.6.5 Lumenis Recent Development
11.7 Galderma
11.7.1 Galderma Company Details
11.7.2 Galderma Business Overview
11.7.3 Galderma Onychomycosis Treatment Introduction
11.7.4 Galderma Revenue in Onychomycosis Treatment Business (2016-2021)
11.7.5 Galderma Recent Development
11.8 Moberg Pharma
11.8.1 Moberg Pharma Company Details
11.8.2 Moberg Pharma Business Overview
11.8.3 Moberg Pharma Onychomycosis Treatment Introduction
11.8.4 Moberg Pharma Revenue in Onychomycosis Treatment Business (2016-2021)
11.8.5 Moberg Pharma Recent Development
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla Onychomycosis Treatment Introduction
11.9.4 Cipla Revenue in Onychomycosis Treatment Business (2016-2021)
11.9.5 Cipla Recent Development
11.10 Biofrontera
11.10.1 Biofrontera Company Details
11.10.2 Biofrontera Business Overview
11.10.3 Biofrontera Onychomycosis Treatment Introduction
11.10.4 Biofrontera Revenue in Onychomycosis Treatment Business (2016-2021)
11.10.5 Biofrontera Recent Development
11.11 Leo Pharma
11.11.1 Leo Pharma Company Details
11.11.2 Leo Pharma Business Overview
11.11.3 Leo Pharma Onychomycosis Treatment Introduction
11.11.4 Leo Pharma Revenue in Onychomycosis Treatment Business (2016-2021)
11.11.5 Leo Pharma Recent Development
11.12 Dr. Reddy's Laboratories
11.12.1 Dr. Reddy's Laboratories Company Details
11.12.2 Dr. Reddy's Laboratories Business Overview
11.12.3 Dr. Reddy's Laboratories Onychomycosis Treatment Introduction
11.12.4 Dr. Reddy's Laboratories Revenue in Onychomycosis Treatment Business (2016-2021)
11.12.5 Dr. Reddy's Laboratories Recent Development
11.13 Medimetriks Pharmaceuticals
11.13.1 Medimetriks Pharmaceuticals Company Details
11.13.2 Medimetriks Pharmaceuticals Business Overview
11.13.3 Medimetriks Pharmaceuticals Onychomycosis Treatment Introduction
11.13.4 Medimetriks Pharmaceuticals Revenue in Onychomycosis Treatment Business (2016-2021)
11.13.5 Medimetriks Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details